FDA Inspection 971651 — Daiichi Sankyo Co., Ltd. Hiratsuka Plant
The FDA completed an inspection of Daiichi Sankyo Co., Ltd. Hiratsuka Plant on Apr 22, 2016 in Hiratsuka. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hiratsuka (Japan)